Enrolling By InvitationNCT06885138
Official study titleStudy of the Clinical and Neurophysiological Effects of Transcranial Direct Current Stimulation on Depressive Symptoms in Parkinson's Disease.
This study is by invitation only.
In MilanDepressionDevice studyAges 35–75
- Countries
- Italy
- Sponsor
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Enrolling By InvitationNCT07198438
Official study titleA Block-Randomized Study Comparing Deep and Standard Prolonged Intermittent Theta Burst Stimulation on Emotional Symptoms and Physiological Indicators in Patients With Major Depression
This study is by invitation only.
In DouliuDepressionDevice studyAges 18–70
- Countries
- Taiwan
- Sponsor
- National Taiwan University Hospital
CompletedNCT02593643
Official study titleA Double-blind Pilot Trial of the Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.
This study has finished and is no longer accepting participants.
In TorontoDepression, Bipolarity, ...Medication studyAges 18–65
- Countries
- Canada
- Sponsor
- Sunnybrook Health Sciences Centre
CompletedNCT07526454
What is this study about?This study evaluated the effectiveness of ketamine for people with depression.
This study has finished and is no longer accepting participants.
In TantaDepressionMedication studyAges 18–75
- Countries
- Egypt
- Sponsor
- Tanta University
CompletedNCT05202119
Official study titleEmpower: Transcranial Direct Current Stimulation in Major Depressive Disorder: a Double-blind, Placebo-controlled, Randomized, Superiority Trial
This study has finished and is no longer accepting participants.
Multiple locations, including HoustonDepressionDevice studyAges 18+
- Countries
- United States, United Kingdom
- Sponsor
- Flow Neuroscience AB
CompletedNCT07253324
What is this study about?This study evaluated the safety of ENX-104 for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including BlackpoolDepressionMedication studyAges 18–65
- Countries
- United Kingdom
- Sponsor
- Engrail Therapeutics INC
Enrolling By InvitationNCT07302165
Official study titlePreParent: Internet-based Digital Tools to Screen for and Prevent Postpartum Depression in Parents-to-be: Identifying and Targeting Cognitive Risk Factors
This study is by invitation only.
In CopenhagenDepressionBehavioural studyAges 18+
- Countries
- Denmark
- Sponsor
- Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
TerminatedNCT04353921
Official study titleA One-Year Observational Follow-up Study of Participants With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control
This study ended early.
In LauderhillDepressionObservational studyAges 21–65
- Countries
- United States
- Sponsor
- Usona Institute
WithdrawnNCT05652465
Official study titleAn Open Trial of Transcranial Magnetic Stimulation for Youth With Treatment-Resistant Major Depressive Disorder
This study was withdrawn before enrollment.
In BethesdaDepressionDevice studyAges 13–17
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH) (Government agency)
Enrolling By InvitationNCT07279311
Official study titleVirtual Reality-enhanced Psychotherapy as a Mental Health Intervention During Antepartum Hospitalization: A Pilot Randomized Controlled Trial
This study is by invitation only.
In Palo AltoDepressionBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- Stanford University
RecruitingEUCTR 2020-005037-32
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
Multiple locations, including Brno-StredDepressionHistorical research record
- Countries
- Czechia
- Sponsor
- Národní ústav duševního zdraví
RecruitingNCT06408012
About this title
An Innovative Master Platform for Clinical Trials in Mood Disorders
Read the official source — NCT06408012Official study titleEnabling Neuroscience Research Approaches for Brain, feeLings and Emotions (ENABLE): An Innovative Platform for Clinical Trials in Mood Disorders
Multiple locations, including CalgaryDepression, BipolarityObservational studyAges 16+
- Countries
- Canada
- Sponsor
- St. Joseph's Healthcare Hamilton